Terms: = Ovarian cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b
92 results:
1. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma.
Miceska S; Skof E; Bucek S; Kuhar CG; Gasljevic G; Smrkolj S; Prevodnik VK
Radiol Oncol; 2023 Dec; 57(4):493-506. PubMed ID: 38038414
[TBL] [Abstract] [Full Text] [Related]
2. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
3. Dedifferentiated and Undifferentiated ovarian Carcinoma: An Aggressive and Molecularly Distinct ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
Tessier-Cloutier B; Kommoss FKF; Kolin DL; Němejcová K; Smith D; Pors J; Stewart CJR; McCluggage WG; Foulkes WD; von Deimling A; Köbel M; Lee CH
Mod Pathol; 2024 Jan; 37(1):100374. PubMed ID: 37925057
[TBL] [Abstract] [Full Text] [Related]
4. NIR-II Fluorescence Imaging for the Detection and Resection of cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic ovarian cancer Models.
Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
[TBL] [Abstract] [Full Text] [Related]
5. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer.
Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J
J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531
[TBL] [Abstract] [Full Text] [Related]
6. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
[TBL] [Abstract] [Full Text] [Related]
7. Dedifferentiated ovarian Carcinoma with ARID1A and arid1b Mutations: A Clinicopathological Report and Literature Review.
Kamal M; Atwi D; Pang H; Li S; Hassell L
Int J Surg Pathol; 2023 Dec; 31(8):1526-1531. PubMed ID: 36843546
[TBL] [Abstract] [Full Text] [Related]
8. Dye-cored polylysine dendrimer as luminescent nanoplatform for imaging-guided anticancer drug delivery.
Zhu P; Younis MR; Ma G; Zhang Q; An R; Wang K; Dong J
Colloids Surf B Biointerfaces; 2023 Feb; 222():113130. PubMed ID: 36623376
[TBL] [Abstract] [Full Text] [Related]
9. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.
Huang J; Li M; Mei B; Li J; Zhu Y; Guo Q; Huang J; Zhang G
J Transl Med; 2022 Oct; 20(1):496. PubMed ID: 36316782
[TBL] [Abstract] [Full Text] [Related]
10. The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future.
Foster JM; Zhang C; Rehman S; Sharma P; Alexander HR
CA Cancer J Clin; 2023 Jan; 73(1):49-71. PubMed ID: 35969103
[TBL] [Abstract] [Full Text] [Related]
11. Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
Tessier-Cloutier B; Kang EY; Alex D; Stewart CJR; McCluggage WG; Köbel M; Lee CH
Histopathology; 2022 Jul; 81(1):44-54. PubMed ID: 35394077
[TBL] [Abstract] [Full Text] [Related]
12. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract] [Full Text] [Related]
13. Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.
Kommoss FK; Tessier-Cloutier B; Witkowski L; Forgo E; Koelsche C; Köbel M; Foulkes WD; Lee CH; Kolin DL; von Deimling A; Howitt BE
J Pathol; 2022 Jun; 257(2):140-145. PubMed ID: 35218556
[TBL] [Abstract] [Full Text] [Related]
14. Novel Interactive Tool for Breast and ovarian cancer Risk Assessment (bright Pink Assess Your Risk): Development and Usability Study.
Hibler EA; Fought AJ; Kershaw KN; Molsberry R; Nowakowski V; Lindner D
J Med Internet Res; 2022 Feb; 24(2):e29124. PubMed ID: 35200148
[TBL] [Abstract] [Full Text] [Related]
15. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
[TBL] [Abstract] [Full Text] [Related]
16. Somatic Mutational Profile of High-Grade Serous ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
17. Optimization of Follicle Isolation for Bioengineering of Human Artificial Ovary.
Chen J; Isachenko E; Wang W; Du X; Wang M; Rahimi G; Mallmann P; Isachenko V
Biopreserv Biobank; 2022 Dec; 20(6):529-539. PubMed ID: 34936496
[No Abstract] [Full Text] [Related]
18. [The composition of ascites lymphocytes in high-grade serous ovarian cancer and its correlation with clinical features].
He TH; Zhang J; Yin ZN; Zhang X; Li Y; Wu Y; Li HJ; Liang HM; Xue LX; Guo HY
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2375-2381. PubMed ID: 34404130
[No Abstract] [Full Text] [Related]
19. ovarian clear cell carcinoma with an immature teratoma component showing ARID1A deficiency and an identical PIK3CA mutation.
Kihara A; Iizuka T; Endo S; Horie K; Kanda H; Niki T
J Obstet Gynaecol Res; 2021 Sep; 47(9):3401-3407. PubMed ID: 34109709
[TBL] [Abstract] [Full Text] [Related]
20. Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
Shah VI; Morgan SE; Köbel M; Lee CH; McCluggage WG
Int J Gynecol Pathol; 2022 Jan; 41(1):35-39. PubMed ID: 33741764
[TBL] [Abstract] [Full Text] [Related]
[Next]
